Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Tax Provisions (2020 - 2025)

Historic Tax Provisions for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to -$2.3 million.

  • Cytek Biosciences' Tax Provisions fell 18750.0% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 5221.65%. This contributed to the annual value of $320000.0 for FY2024, which is 10898.62% up from last year.
  • Latest data reveals that Cytek Biosciences reported Tax Provisions of -$2.3 million as of Q3 2025, which was down 18750.0% from -$1.2 million recorded in Q2 2025.
  • In the past 5 years, Cytek Biosciences' Tax Provisions registered a high of $3.2 million during Q2 2024, and its lowest value of -$2.8 million during Q1 2024.
  • In the last 5 years, Cytek Biosciences' Tax Provisions had a median value of $50000.0 in 2021 and averaged -$254421.1.
  • Per our database at Business Quant, Cytek Biosciences' Tax Provisions plummeted by 239000.0% in 2022 and then skyrocketed by 92678.57% in 2023.
  • Over the past 5 years, Cytek Biosciences' Tax Provisions (Quarter) stood at $1.6 million in 2021, then crashed by 75.39% to $396000.0 in 2022, then tumbled by 443.69% to -$1.4 million in 2023, then skyrocketed by 152.9% to $720000.0 in 2024, then tumbled by 419.44% to -$2.3 million in 2025.
  • Its Tax Provisions was -$2.3 million in Q3 2025, compared to -$1.2 million in Q2 2025 and $136000.0 in Q1 2025.